Telomir制药公司的Telomir-1号小分子显示,在一项有关老年狗的小型研究中,包括一项在消退期患终期癌症的研究中,取得了有希望的结果。 Telomir Pharmaceuticals' Telomir-1 small molecule shows promising results in a small study on senior dogs, including one with terminal cancer in remission.
Telomir制药公司是一家长寿科学公司,它报告说,利用Telomir-1小分子对两只高级狗进行了一项小型研究,取得了积极的成果。 Telomir Pharmaceuticals, a longevity science company, reports positive results from a small study with two senior dogs using its Telomir-1 small molecule. 治疗使健康和生命力得到显著改善,包括一只狗完全摆脱了绝症癌症。 The treatment led to significant improvements in health and vitality, including one dog experiencing complete remission of terminal cancer. 虽然在临床前期发展阶段,尚未对人体进行测试,但结果令人鼓舞,可以在今后对人体进行潜在应用。 While in preclinical development and not yet tested on humans, the results are encouraging for potential future applications in humans.